Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”

doi:10.4251/wjgo.v15.i9.1673

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 9

This Article

Table of Contents

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3551)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

148

WORD

HTML

1598

Figures (1-1)

489

Sum=2262

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

301

Download

789

Sum=1090

Sep 15, 2023 (publication date) through Mar 2, 2026

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Correction Open Access

World J Gastrointest Oncol. Sep 15, 2023; 15(9): 1673-1674
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1673

Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”

This corrects the article "Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells".

Chuan-Hong Li, Zhang-Ming Chen, Pei-Feng Chen, Lei Meng, Wan-Nian Sui, Song-Cheng Ying, A-Man Xu, Wen-Xiu Han

Chuan-Hong Li, Zhang-Ming Chen, Pei-Feng Chen, Lei Meng, Wan-Nian Sui, A-Man Xu, Wen-Xiu Han, Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China

Song-Cheng Ying, Department of Immunology, College of Basic Medicine, Anhui Medical University, Hefei 230022, Anhui Province, China

ORCID number: Chuan-Hong Li (0000-0002-3945-972X); Zhang-Ming Chen (0000-0002-4830-0745); Pei-Feng Chen (0000-0003-2843-425X); Lei Meng (0000-0002-1089-1228); Wan-Nian Sui (0000-0002-4337-5238); Song-Cheng Ying (0000-0002-3446-4482); A-Man Xu (0000-0002-7171-5295); Wen-Xiu Han (0000-0002-5335-9645).

Author contributions: Li CH wrote the manuscript; All authors approved the submitted version.

Conflict-of-interest statement: There is no conflict of interest in this study.

Corresponding author: Wen-Xiu Han, MD, PhD, Professor, Department of General Surgery, First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Avenue, Shushan District, Hefei 230022, Anhui Province, China. hwxhbh@126.com

Received: May 16, 2023
Peer-review started: May 16, 2023
First decision: June 26, 2023
Revised: July 7, 2023
Accepted: July 31, 2023
Article in press: July 31, 2023
Published online: September 15, 2023
Processing time: 120 Days and 9 Hours

Abstract

Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”. In this article, we found the following error in Figure 3A: The panel image "24 h, sh-RNA1" in the AGS cells wound healing assay was incorrectly inserted during the preparation of the submission; the correct figure is provided in this correction.

Key Words: Correction; Gastric cancer; Interleukin-34; Proliferation; Epithelial-mesenchymal transition; Metastasis

Core Tip: The aim of this manuscript is to correct the image in Figure 3A of “Li CH, Chen ZM, Chen PF, Meng L, Sui WN, Ying SC, Xu AM, Han WX. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells. World J Gastrointest Oncol 2022; 14: 1968-1980 [PMID: 36310707 DOI: 10.4251/ wjgo.v14.i10.1968].

Citation: Li CH, Chen ZM, Chen PF, Meng L, Sui WN, Ying SC, Xu AM, Han WX. Correction to “Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells”. World J Gastrointest Oncol 2023; 15(9): 1673-1674
URL: https://www.wjgnet.com/1948-5204/full/v15/i9/1673.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i9.1673

TO THE EDITOR

Correction to: Li CH, Chen ZM, Chen PF, Meng L, Sui WN, Ying SC, Xu AM, Han WX. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells. World J Gastrointest Oncol 2022; 14: 1968-1980 [PMID: 36310707 DOI: 10.4251/wjgo.v14.i10.1968]. We identified the following error in Figure 3A of the original version of the published article: The image relative to "24 h, sh-RNA1" in the AGS cell wound healing assay was inserted incorrectly during the preparation of the submission. The correct Figure is provided in this correction (Figure 1). This correction will have no influence on the interpretation of the results and conclusion in this study. We apologize for any inconvenience this may have caused.

Open in New Tab Full Size Figure Download Figure

Figure 1 Interleukin-34 regulates the migration and invasiveness of AGS cells. A and B: Wound-healing assay revealed that downregulation of endogenous interleukin-34 significantly reduced the migration rate. Data derived from three independent experiments performed in triplicate and expressed as mean ± SD, and ^aP < 0.05 was considered statistically significant.

References

Li CH, Chen ZM, Chen PF, Meng L, Sui WN, Ying SC, Xu AM, Han WX. Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells. World J Gastrointest Oncol. 2022;14:1968-1980. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 5] [Cited by in RCA: 6] [Article Influence: 1.5] [Reference Citation Analysis (0)]

Footnotes

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Oncology

Country/Territory of origin: China

Peer-review report’s scientific quality classification

Grade A (Excellent): A

Grade B (Very good): 0

Grade C (Good): C, C

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Senchukova M, Russia; Sheykhhasan M, Iran; Yildiz K, Turkey S-Editor: Fan JR L-Editor: A P-Editor: Xu ZH